Skip to Content

Fresenius SE & Co KGaA ADR FSNUY

Morningstar Rating
$6.97 −0.10 (1.41%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

FSNUY is trading within a range we consider fairly valued.
Price
$6.98
Fair Value
$53.97
Uncertainty
Very High
1-Star Price
$58.88
5-Star Price
$2.30
Economic Moat
Rnpjq
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if FSNUY is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$7.07
Day Range
$6.926.98
52-Week Range
$6.078.38
Bid/Ask
$4.81 / $9.46
Market Cap
$15.70 Bil
Volume/Avg
27,417 / 25,957

Key Statistics

Price/Earnings (Normalized)
8.97
Price/Sales
0.54
Dividend Yield (Trailing)
3.56%
Dividend Yield (Forward)
Total Yield
3.56%

Company Profile

Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals and fertility clinics in Germany, Spain, and Latin America. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.
Sector
Healthcare
Industry
Medical Care Facilities
Stock Style Box
Large Value
Total Number of Employees
193,527

Competitors

Valuation

Metric
FSNUY
DVA
BAX
Price/Earnings (Normalized)
8.9714.7314.68
Price/Book Value
0.7410.382.39
Price/Sales
0.540.951.35
Price/Cash Flow
5.976.1713.99
Price/Earnings
FSNUY
DVA
BAX

Financial Strength

Metric
FSNUY
DVA
BAX
Quick Ratio
0.181.060.91
Current Ratio
1.541.191.48
Interest Coverage
4.553.950.66
Quick Ratio
FSNUY
DVA
BAX

Profitability

Metric
FSNUY
DVA
BAX
Return on Assets (Normalized)
2.02%6.40%4.63%
Return on Equity (Normalized)
7.58%112.35%19.64%
Return on Invested Capital (Normalized)
3.46%10.05%6.97%
Return on Assets
FSNUY
DVA
BAX
See how this stock stacks up to its competitors with Morningstar Investor

Medical Care Facilities Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
HCA
HCA Healthcare IncZzfdfng$82.7 Bil
FSNUF
Fresenius SE & Co KGaAQlvrfwh$15.7 Bil
BDULF
Bangkok Dusit Medical Services PCL Shs Foreign RegisteredYhp$13.3 Bil
JDHIF
JD Health International IncXhsfcx$12.5 Bil
JDHIY
JD Health International Inc ADRYnlyfmm$12.5 Bil
FMS
Fresenius Medical Care AG ADRPjlsqm$11.4 Bil
DVA
DaVita IncMpjbf$10.7 Bil
THC
Tenet Healthcare CorpYzqd$9.2 Bil
AMN
AMN Healthcare Services IncBlcrxzz$2.2 Bil

Sponsor Center